Oral contraceptives and the risk of multiple sclerosis: A review of the epidemiologic evidence

Journal of the Neurological Sciences

Volumn 286, Issue 1-2, 2009, Pages 73-75

  Alonso, Alvaro ^a,b   Clark, Cari Jo ^c  

^a UNIVERSITY OF MINNESOTA   (United States)

^b UNIVERSITY OF NAVARRA   (Spain)

^c UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

Epidemiology; Estrogens; Multiple sclerosis; Oral contraceptive

Indexed keywords

ORAL CONTRACEPTIVE AGENT;

ADULT; ARTICLE; DATA BASE; DEMYELINATING DISEASE; FAMILY PLANNING; FEMALE; GENERAL PRACTICE; GENERAL PRACTITIONER; HUMAN; MAJOR CLINICAL STUDY; MULTIPLE SCLEROSIS; NURSE; ORAL CONTRACEPTION; POPULATION RISK; PRIORITY JOURNAL; QUESTIONNAIRE; RISK ASSESSMENT; RISK FACTOR; UNITED KINGDOM; WOMEN'S HEALTH;

CONTRACEPTIVES, ORAL; DATABASES, BIBLIOGRAPHIC; FEMALE; HUMANS; MULTIPLE SCLEROSIS; RISK FACTORS;

EID: 70349781936     PISSN: 0022510X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jns.2009.04.038     Document Type: Article

References (27)

1. Noseworthy J.H., Lucchinetti C., Rodriguez M., and Weinshenker B.G. Multiple sclerosis. N Engl J Med 343 (2000) 938-952
2. Alonso A., and Hernán M.A. Temporal trends in the incidence of multiple sclerosis: a systematic review. Neurology 71 (2008) 129-135
3. Confavreux C., Hutchinson M., Hours M.M., Cortinovis-Tourniaire P., and Moreau T. Rate of pregnancy-related relapse in multiple sclerosis. Pregnancy in Multiple Sclerosis Group. N Engl J Med 339 (1998) 285-291
4. Gilmore W., Arias M., Stroud N., Stek A., McCarthy K.A., and Correale J. Preliminary studies of cytokine secretion patterns associated with pregnancy in MS patients. J Neurol Sci 224 (2004) 69-76
5. Offner H., and Polanczyk M. A potential role for estrogen in experimental autoimmune encephalomyelitis and multiple sclerosis. Ann N Y Acad Sci 1089 (2006) 353-372
6. Bebo Jr. B.F., Fyfe-Johnson A., Adlard K., Beam A.G., Vandenbark A.A., and Offner H. Low-dose estrogen therapy ameliorates experimental autoimmune encephalomyelitis in two different inbred mouse strains. J Immunol 166 (2001) 2080-2089
7. Subramanian S., Matejuk A., Zamora A., Vandenbark A.A., and Offner H. Oral feeding with ethinyl estradiol suppresses and treats experimental autoimmune encephalomyelitis in SJL mice and inhibits the recruitment of inflammatory cells into the central nervous system. J Immunol 170 (2003) 1548-1555
8. Ito A., Bebo Jr. B.F., Matejuk A., Zamora A., Silverman M., Fyfe-Johnson A., et al. Estrogen treatment down-regulates TNF-alpha production and reduces the severity of experimental autoimmune encephalomyelitis in cytokine knockout mice. J Immunol 167 (2001) 542-552
9. Matejuk A., Adlard K., Zamora A., Silverman M., Vandenbark A.A., and Offner H. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis. J Neurosci Res 65 (2001) 529-542
10. Adamski J., Ma Z., Nozell S., and Benveniste E.N. 17beta-estradiol inhibits class II major histocompatibility complex (MHC) expression: influence on histone modifications and CBP recruitment to the class II MHC promoter. Mol Endocrinol 18 (2004) 1963-1974
11. Liu H.Y., Buenafe A.C., Matejuk A., Ito A., Zamora A., Dwyer J., et al. Estrogen inhibition of EAE involves effects on dendritic cell function. J Neurosci Res 70 (2002) 238-248
12. Morales L.B.J., Loo K.K., Liu H.-B., Peterson C., Tiwari-Woodruff S., and Voskuhl R.R. Treatment with an estrogen receptor alpha ligand is neuroprotective in experimental autoimmune encephalomyelitis. J Neurosci 26 (2006) 6823-6833
13. Vessey M.P., and Lawless M. The Oxford-Family Planning Association contraceptive study. Clin Obstet Gynaecol 11 (1984) 743-757
14. Vessey M., and Yeates D. Oral contraceptives and benign breast disease: an update of findings in a large cohort study. Contraception 76 (2007) 418-424
15. Villard-Mackintosh L., and Vessey M.P. Oral contraceptives and reproductive factors in multiple sclerosis incidence. Contraception 47 (1993) 161-168
16. Hannaford P.C., Selvaraj S., Elliott A.M., Angus V., Iversen L., and Lee A.J. Cancer risk among users of oral contraceptives: cohort data from the Royal College of General Practitioner's oral contraception study. BMJ 335 (2007) 651
17. Thorogood M., and Hannaford P.C. The influence of oral contraceptives on the risk of multiple sclerosis. Br J Obstet Gynaecol 105 (1998) 1296-1299
18. Hernán M.A., Hohol M.J., Olek M.J., Spiegelman D., and Ascherio A. Oral contraceptives and the incidence of multiple sclerosis. Neurology 55 (2000) 848-854
19. Poser C.M., Paty D.W., Scheinberg L., McDonald W.I., Davis F.A., Ebers G.C., et al. New diagnostic criteria for multiple sclerosis: guidelines for research protocols. Ann Neurol 13 (1983) 227-231
20. Jick H., Jick S.S., and Derby L.E. Validation of information recorded on general practitioner based computerised data resource in the United Kingdom. BMJ 302 (1991) 766-768
21. García Rodríguez L.A., and Pérez Gutthann S. Use of the UK General Practice Research Database for pharmacoepidemiology. Br J Clin Pharmacol 45 (1998) 419-425
22. Jick S.S., Kaye J.A., Vasilakis-Scaramozza C., García Rodríguez L.A., Ruigómez A., Meier C.R., et al. Validity of the General Practice Research Database. Pharmacotherapy 23 (2003) 686-689
23. McDonald W.I., Compston A., Edan G., Goodkin D., Hartung H.P., Lublin F.D., et al. Recommended diagnostic criteria for multiple sclerosis: guidelines from the International Panel on the diagnosis of multiple sclerosis. Ann Neurol 50 (2001) 121-127
24. Hernán M.A., Jick S.S., Olek M.J., and Jick H. Recombinant hepatitis B vaccine and the risk of multiple sclerosis. A prospective study. Neurology 63 (2004) 838-842
25. Alonso A., Jick S.S., Olek M.J., Ascherio A., Jick H., and Hernán M.A. Recent use of oral contraceptives and the risk of multiple sclerosis. Arch Neurol 62 (2005) 1362-1365
26. Poser S., Raun N.E., Wikstrom J., and Poser W. Pregnancy, oral contraceptives and multiple sclerosis. Acta Neurol Scand 59 (1979) 108-118
27. Holmqvist P., Wallberg M., Hammar M., Landtblom A.M., and Brynhildsen J. Symptoms of multiple sclerosis in women in relation to sex steroid exposure. Maturitas 54 (2006) 149-153